Tip: Index histories & All-time highs

Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Mon, 23.09.2024       INFICON Holding AG
CH0011029946

INFICON Holding AG / Key word(s): Miscellaneous INFICON Receives 2024 Supplier Excellence Award from Lam Research 23.09.2024 / 17:40 CET/CEST Corporate Contact Matthias Tröndle Chief Financial Officer +423 388 3510 matthias.troendle@inficon.com   Announcement of INFICON Holding AGBad Ragaz/Switzerland, September 23, 2024 INFI [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       INFICON Holding AG
CH0011029946

INFICON Holding AG / Key word(s): Miscellaneous INFICON Receives 2024 Supplier Excellence Award from Lam Research 23.09.2024 / 17:40 CET/CEST Corporate Contact Matthias Tröndle Chief Financial Officer +423 388 3510 matthias.troendle@inficon.com   Announcement of INFICON Holding AGBad Ragaz/Switzerland, September 23, 2024 INFI [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       AT&S Austria Technologie & Systemtechnik AG
AT0000969985

    AT&S announces the successful signing of the transaction related to the plant in Ansan / South Korea   On September 23, 2024, AT&S and the Italian company SO.MA.CI.S. S.p.A. signed an agreement for the sale of AT&S Korea CO., LTD. and thus the AT&S plant in Ansan, South Korea. The purchase price (equity value) amounts to app [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       AT&S Austria Technologie & Systemtechnik AG
AT0000969985

    AT&S announces the successful signing of the transaction related to the plant in Ansan / South Korea   On September 23, 2024, AT&S and the Italian company SO.MA.CI.S. S.p.A. signed an agreement for the sale of AT&S Korea CO., LTD. and thus the AT&S plant in Ansan, South Korea. The purchase price (equity value) amounts to app [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       STRABAG SE
AT000000STR1

NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, INTO OR WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION IS UNLAWFULSTRABAG SE: Shares from 2024 capital increase being rebooked to regular ISIN AT000000STR Last day of trading for shares in the temporary ISIN (AT0000A3 [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       STRABAG SE
AT000000STR1

NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, INTO OR WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION IS UNLAWFULSTRABAG SE: Shares from 2024 capital increase being rebooked to regular ISIN AT000000STR Last day of trading for shares in the temporary ISIN (AT0000A3 [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024 Ladenburg, Germany, 23 September 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage company developing innovative Antibody Drug Conjugates (ADCs), today announces that new data from [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024 Ladenburg, Germany, 23 September 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage company developing innovative Antibody Drug Conjugates (ADCs), today announces that new data from [ … ]
Technical analysis
To the publication
Mon, 23.09.2024       Artcline GmbH

ARTCLINE appoints Dirk Hessel as Managing Director and Prepares the Market Entry for Innovative Septic Shock Treatment ARTCLINE is strengthening its management team with an experienced pharmaceutical leader to set up a sales force and accelerate strategic growth ARTICE® is a therapy utilizing allogenic immune cells to strengthen the immunocompet [ … ]
To the publication
Mon, 23.09.2024       Artcline GmbH

ARTCLINE appoints Dirk Hessel as Managing Director and Prepares the Market Entry for Innovative Septic Shock Treatment ARTCLINE is strengthening its management team with an experienced pharmaceutical leader to set up a sales force and accelerate strategic growth ARTICE® is a therapy utilizing allogenic immune cells to strengthen the immunocompet [ … ]
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 26.11.2024, Calendar Week 48, 331st day of the year, 35 days remaining until EoY.